Alterations in TP53 in localized or metastatic hormone-sensitive PCa also had a shorter time to CRPC, and cumulative gene hits in TP53, PTEN, and RB1 led to an incremental risk of progression with inferior OS with increasing gene hits [52]. The gene discussed is TP53; the disease is posterior cortical atrophy.